AMN:NYE-AMN Healthcare Services Inc (USD)

COMMON STOCK | Medical Care Facilities | NYE

Last Closing Price

USD 114.23

Change

+0.87 (+0.77)%

Market Cap

USD 4.94B

Volume

0.32M

Avg Analyst Target

USD 146.20 (+27.99%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


AMN Stock Forecast & Price:
Based on the AMN Healthcare Services Inc stock forecasts from 3 analysts, the average analyst target price for AMN Healthcare Services Inc is USD 146.20 over the next 12 months. AMN Healthcare Services Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of AMN Healthcare Services Inc is Bullish , which is based on 8 positive signals and 3 negative signals. At the last closing, AMN Healthcare Services Inc’s stock price was USD 114.23. AMN Healthcare Services Inc’s stock price has changed by -3.06% over the past week, +2.49% over the past month and +8.31% over the last year.

About AMN Healthcare Services Inc (AMN:NYE)

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to hospitals and healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforc ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-08-12 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
HCA HCA Holdings Inc

+2.37 (+1.09%)

USD62.52B 10.45 7.36
FMS Fresenius Medical Care Corpora..

+0.03 (+0.16%)

USD11.06B 13.43 7.02
AGL agilon health Inc

-2.36 (-9.17%)

USD9.61B N/A -105.97
UHS Universal Health Services Inc

+0.57 (+0.51%)

USD8.13B 11.47 7.99
DVA DaVita HealthCare Partners Inc

+0.89 (+0.97%)

USD7.82B 10.55 8.50
CHE Chemed Corp

+6.89 (+1.42%)

USD7.21B 26.96 17.63
OSH Oak Street Health Inc

+0.97 (+3.36%)

USD7.07B N/A -16.45
THC Tenet Healthcare Corporation

+1.77 (+2.71%)

USD7.04B 8.21 5.67
EHC Encompass Health Corp

+0.95 (+1.80%)

USD5.29B 16.22 8.58
SEM Select Medical Holdings

+0.98 (+3.66%)

USD3.46B 15.90 12.10

ETFs Containing AMN

Symbol Name Weight Mer Price(Change) Market Cap
IJR iShares Core S&P Small-Ca.. 0.00 % 0.06 %

+1.85 (+1.78%)

USD69.96B
PSCH Invesco S&P SmallCap Heal.. 0.00 % 0.29 %

+2.65 (+1.75%)

USD0.36B
SAA ProShares Ultra SmallCap6.. 0.00 % 0.95 %

+0.89 (+3.48%)

USD0.03B
SLY SPDR® S&P 600 Small Cap .. 0.00 % 0.15 %

+1.65 (+1.84%)

USD1.79B
HERS:CA Evolve North American Gen.. 0.00 % 0.40 %

N/A

USD3.37M
HERS-B:CA Evolve North American Gen.. 0.00 % 0.40 %

N/A

N/A
SMLE DBX ETF Trust - S&P Small.. 0.00 % 0.15 %

+0.40 (+1.60%)

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -6.62% 73% C 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.62% 68% D+ 56% F
Trailing 12 Months  
Capital Gain 8.11% 100% A+ 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.11% 100% A+ 82% B-
Trailing 5 Years  
Capital Gain 212.96% 93% A 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 212.96% 93% A 95% A
Average Annual (5 Year Horizon)  
Capital Gain 24.64% 82% B- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.64% 82% B- 86% B
Risk Return Profile  
Volatility (Standard Deviation) 36.34% 45% F 29% F
Risk Adjusted Return 67.82% 91% A- 86% B
Market Capitalization 4.94B 59% F 74% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 11.56 67% D+ 67% D+
Price/Book Ratio 4.85 40% F 16% F
Price / Cash Flow Ratio 16.19 23% F 25% F
EV/EBITDA 7.42 64% D 55% F
Management Effectiveness  
Return on Equity 45.87% 100% A+ 93% A
Return on Invested Capital 19.61% 91% A- 86% B
Return on Assets 14.77% 95% A 95% A
Debt to Equity Ratio 72.49% 57% F 48% F
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 6.50 32% F 14% F
Short Percent 15.39% 14% F 25% F
Beta 0.26 95% A 91% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.